Nomura Signs Investor Statement Expressing Concerns Regarding
Antimicrobial Resistance (AMR)
Tokyo, July 22, 2024—Nomura Asset Management Co., Ltd. (NAM), the core company within theInvestment Management Division of Nomura Group, today announced that it has signed an investor
statement expressing concerns regarding antimicrobial resistance (AMR 1), a critical issue whereantibiotics lose their effectiveness against bacteria.
This statement, initiated by IAAMR (Investor Action on Antimicrobial Resistance), calls upon
investors globally to tackle the challenges posed by AMR. NAM is actively engaged with the Accessto Medicine Foundation 2 and FAIRR 3 initiatives, the founding collaborators supporting IAAMR.
Driven by global overuse and misuse of antimicrobials in humans, animals and agriculture, and thesubsequent spread of antimicrobial residues into the environment, AMR has become a systemicrisk akin to climate change and nature loss. Therefore NAM signed the statement to pledge our
support on these issues.
IAAMR has highlighted the potential negative impact on the global GDP if AMR issues remain
unaddressed. The UN General Assembly’s second High Level Meeting (HLM) on AMR is set toconvene in September 2024, marking the first such meeting in eight years since the inauguralsession in 2016.
The statement underscores the necessity for all stakeholders, including governments, investors,and companies, to actively engage in efforts to mitigate the risks of AMR by embracing a holistic"One Health" approach that recognizes the interconnectedness of human, animal, andenvironmental health. In line with this ethos, the statement calls for seven key actions, such as
establishing "science-based guidance targets," reductions in the use of antibiotics in agriculture andanimal farming, and funding the development of new antimicrobials, to be enacted by policymakers
worldwide.
As a responsible institutional investor, NAM will continue to address ESG issues in order to become
the asset manager of choice for clients around the world.
ends
NomuraNomura is a global financial services group with an integrated network spanning over 30 countries and regions. By
connecting markets East & West, Nomura services the needs of individuals, institutions, corporates and governments
through its three business divisions: Wealth Management, Investment Management, and Wholesale (Global Markets andInvestment Banking). Founded in 1925, the firm is built on a tradition of disciplined entrepreneurship, serving clients withcreative solutions and considered thought leadership. For further information about Nomura, visit www.nomura.com.

1Please refer to the Ministry of Health, Labour and Welfare's "National Action Plan on Antimicrobial Resistance (AMR) 2023-2027" formore details. https://www.mhlw.go.jp/content/10900000/001096228.pdf
2A foundation that encourages the pharmaceutical industry to do more to help low- and middle-income countries who have limitedaccess to medicine. NAM endorsed and signed the Access to Medicine Index published by the foundation in 2019.
3The Farm Animal Investment Risk and Return initiative. A livestock industry-related institutional investor initiative, which educatespeople about livestock industry risks, including the impact on the environment, as well as food safety (antibiotics) issues. NAM signed
on to this initiative in 2019.